Alkermes Plc Stock Today

ALKS Stock  USD 27.25  0.47  1.76%   

Performance

0 of 100

 
Low
 
High
Very Weak

Odds Of Distress

Less than 9

 
100  
 
Zero
Low
Alkermes Plc is selling for under 27.25 as of the 29th of March 2024; that is 1.76 percent increase since the beginning of the trading day. The stock's lowest day price was 26.99. Alkermes Plc has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Alkermes Plc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of February 2024 and ending today, the 29th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
16th of July 1991
Category
Healthcare
Classification
Health Care
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland. The company has 167.08 M outstanding shares of which 14.08 M shares are presently shorted by private and institutional investors with about 5.47 trading days to cover. More on Alkermes Plc

Alkermes Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Alkermes Plc's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Alkermes Plc or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Alkermes Plc's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alkermes Plc's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
Chairman and CEORichard Pops
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, SP Small-Cap 600, NASDAQ Biotechnology, ARCA Biotechnology, Dow Jones Biotechnology, ARCA Pharmaceutical, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal Testing
Average Analyst Recommendation
Analysts covering Alkermes Plc report their recommendations after researching Alkermes Plc's financial statements, talking to executives and customers, or listening in on Alkermes Plc's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Alkermes Plc. The Alkermes consensus assessment is calculated by taking the average forecast from all of the analysts covering Alkermes Plc.
Alkermes Plc's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Alkermes Plc's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Alkermes Plc's financial leverage. It provides some insight into what part of Alkermes Plc's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Alkermes Plc's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Alkermes Plc deploys its capital and how much of that capital is borrowed.
Liquidity
Alkermes Plc cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 290.73 M in liabilities with Debt to Equity (D/E) ratio of 0.38, which is about average as compared to similar companies. Alkermes Plc has a current ratio of 2.33, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Alkermes Plc until it has trouble settling it off, either with new capital or with free cash flow. So, Alkermes Plc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Alkermes Plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Alkermes to invest in growth at high rates of return. When we think about Alkermes Plc's use of debt, we should always consider it together with cash and equity.

Net Income

545.11 Million
Alkermes Plc (ALKS) is traded on NASDAQ Exchange in USA. It is located in Connaught House, Dublin, Ireland, D04 C5Y6 and employs 2,100 people. Alkermes Plc is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.52 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Alkermes Plc's market, we take the total number of its shares issued and multiply it by Alkermes Plc's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Alkermes Plc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 167.08 M outstanding shares of which 14.08 M shares are presently shorted by private and institutional investors with about 5.47 trading days to cover. Alkermes Plc currently holds about 580.97 M in cash with 401.35 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.54.
Check Alkermes Plc Probability Of Bankruptcy
Ownership Allocation
Alkermes Plc retains a total of 167.08 Million outstanding shares. The majority of Alkermes Plc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alkermes Plc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alkermes Plc. Please pay attention to any change in the institutional holdings of Alkermes Plc as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Alkermes Ownership Details

Alkermes Stock Price Odds Analysis

Attributed to a normal probability distribution, the odds of Alkermes Plc jumping above the current price in 90 days from now is about 82.27%. The Alkermes Plc probability density function shows the probability of Alkermes Plc stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Alkermes Plc has a beta of -1.2338. This suggests as returns on its benchmark rise, returns on holding Alkermes Plc are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Alkermes Plc is expected to outperform its benchmark. Additionally, alkermes Plc has an alpha of 0.1643, implying that it can generate a 0.16 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 27.25HorizonTargetOdds Above 27.25
17.56%90 days
 27.25 
82.27%
Based on a normal probability distribution, the odds of Alkermes Plc to move above the current price in 90 days from now is about 82.27 (This Alkermes Plc probability density function shows the probability of Alkermes Stock to fall within a particular range of prices over 90 days) .

Alkermes Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Alkermes Plc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Alkermes Plc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Alkermes Plc's value.
InstituionRecorded OnShares
Primecap Management Company2023-12-31
3.6 M
Bank Of New York Mellon Corp2023-12-31
3.3 M
Goldman Sachs Group Inc2023-12-31
2.8 M
Morgan Stanley - Brokerage Accounts2023-12-31
2.5 M
Dimensional Fund Advisors, Inc.2023-12-31
2.4 M
Charles Schwab Investment Management Inc2023-12-31
2.1 M
Artisan Partners Limited Partnership2023-12-31
2.1 M
Norges Bank2023-12-31
M
Nuveen Asset Management, Llc2023-12-31
M
Blackrock Inc2023-12-31
30 M
Vanguard Group Inc2023-12-31
21 M
View Alkermes Plc Diagnostics

Alkermes Plc Historical Income Statement

Alkermes Plc Income Statement is one of the three primary financial statements used for reporting Alkermes's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Alkermes Plc revenue and expense. Alkermes Plc Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Alkermes Plc's Income Before Tax is comparatively stable compared to the past year. Net Income is likely to gain to about 373.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 162.4 M in 2024. View More Fundamentals

Alkermes Stock Against Markets

Picking the right benchmark for Alkermes Plc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Alkermes Plc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Alkermes Plc is critical whether you are bullish or bearish towards Alkermes Plc at a given time. Please also check how Alkermes Plc's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Alkermes Plc without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Price Transformation Now

   

Price Transformation

Use Price Transformation models to analyze the depth of different equity instruments across global markets
All  Next Launch Module

Alkermes Plc Corporate Directors

Alkermes Plc corporate directors refer to members of an Alkermes Plc board of directors. The board of directors generally takes responsibility for the Alkermes Plc's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Alkermes Plc's board members must vote for the resolution. The Alkermes Plc board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Nancy SnydermanDirectorProfile
Nancy WysenskiDirectorProfile
Floyd BloomIndependent DirectorProfile
Robert BreyerIndependent DirectorProfile

How to buy Alkermes Stock?

Before investing in Alkermes Plc, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Alkermes Plc. To buy Alkermes Plc stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Alkermes Plc. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Alkermes Plc stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Alkermes Plc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Alkermes Plc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Alkermes Plc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.

Already Invested in Alkermes Plc?

The danger of trading Alkermes Plc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Alkermes Plc is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Alkermes Plc. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Alkermes Plc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Alkermes Plc is a strong investment it is important to analyze Alkermes Plc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Alkermes Plc's future performance. For an informed investment choice regarding Alkermes Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alkermes Plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry.
For more information on how to buy Alkermes Stock please use our How to Invest in Alkermes Plc guide.
You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Alkermes Stock analysis

When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Alkermes Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alkermes Plc. If investors know Alkermes will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alkermes Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
3.06
Revenue Per Share
10.007
Quarterly Revenue Growth
0.239
Return On Assets
0.1281
Return On Equity
0.4622
The market value of Alkermes Plc is measured differently than its book value, which is the value of Alkermes that is recorded on the company's balance sheet. Investors also form their own opinion of Alkermes Plc's value that differs from its market value or its book value, called intrinsic value, which is Alkermes Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alkermes Plc's market value can be influenced by many factors that don't directly affect Alkermes Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alkermes Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alkermes Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alkermes Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.